BTG
Encyclopedia
BTG plc a public limited company
is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products. The company is a constituent of the FTSE 250 Index
.
was formed with the purpose of commercialising innovations that arose from public funded research
. This was complemented in November 1975 by the establishment of the National Enterprise Board
to implement the then-Government's policy of moving public sector industry into commercial private enterprise.
These two organisations were merged by the Government in 1981 to form a new, non-statutory body called the British Technology Group. It acted principally as a technology transfer company, licencing and commercialising the use of publicly-funded developments. The Group was put onto a statutory footing in the British Technology Group Act, 1991 with HM Treasury
initially being the only shareholder. Subsequently, in March 1992, Cinven
arranged a management buy-out from the Government. The company later floated on the London Stock Exchange
in 1995. Three years later, on 27 May 1998, the Group adopted its present name. It now focuses its work on developing and commercialising medical innovations.
Since acquiring the commercialisation rights to magnetic resonance imaging
(MRI) (under a revenue share scheme) in 1983, BTG has come to licence a large part of the world market in MRI, including licencees such as General Electric
and Philips
.
The Company's active development pipeline includes the following products:
In addition BTG has several programmes it intends to partner as they reach key development milestones.
Public limited company
A public limited company is a limited liability company that sells shares to the public in United Kingdom company law, in the Republic of Ireland and Commonwealth jurisdictions....
is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products. The company is a constituent of the FTSE 250 Index
FTSE 250 Index
The FTSE 250 Index is a capitalisation-weighted index consisting of the 101st to the 350th largest companies on the London Stock Exchange. Promotions to and demotions from the index take place quarterly in March, June, September and December...
.
History
In 1948, the National Research Development CorporationNational Research Development Corporation
The National Research Development Corporation was a non-departmental government body established by the British Government to transfer technology from the public sector to the private sector.-History:...
was formed with the purpose of commercialising innovations that arose from public funded research
Research
Research can be defined as the scientific search for knowledge, or as any systematic investigation, to establish novel facts, solve new or existing problems, prove new ideas, or develop new theories, usually using a scientific method...
. This was complemented in November 1975 by the establishment of the National Enterprise Board
National Enterprise Board
-History:The National Enterprise Board was set up in the United Kingdom in 1975 to implement the Wilson Labour government's objective of extending public ownership of industry...
to implement the then-Government's policy of moving public sector industry into commercial private enterprise.
These two organisations were merged by the Government in 1981 to form a new, non-statutory body called the British Technology Group. It acted principally as a technology transfer company, licencing and commercialising the use of publicly-funded developments. The Group was put onto a statutory footing in the British Technology Group Act, 1991 with HM Treasury
HM Treasury
HM Treasury, in full Her Majesty's Treasury, informally The Treasury, is the United Kingdom government department responsible for developing and executing the British government's public finance policy and economic policy...
initially being the only shareholder. Subsequently, in March 1992, Cinven
Cinven
Cinven is a British private equity firm founded in 1977 with offices in London, Paris, Frankfurt, Milan and Hong Kong. Currently, the company has raised four funds, with the last one signing up €6.5 billion...
arranged a management buy-out from the Government. The company later floated on the London Stock Exchange
London Stock Exchange
The London Stock Exchange is a stock exchange located in the City of London within the United Kingdom. , the Exchange had a market capitalisation of US$3.7495 trillion, making it the fourth-largest stock exchange in the world by this measurement...
in 1995. Three years later, on 27 May 1998, the Group adopted its present name. It now focuses its work on developing and commercialising medical innovations.
Since acquiring the commercialisation rights to magnetic resonance imaging
Magnetic resonance imaging
Magnetic resonance imaging , nuclear magnetic resonance imaging , or magnetic resonance tomography is a medical imaging technique used in radiology to visualize detailed internal structures...
(MRI) (under a revenue share scheme) in 1983, BTG has come to licence a large part of the world market in MRI, including licencees such as General Electric
General Electric
General Electric Company , or GE, is an American multinational conglomerate corporation incorporated in Schenectady, New York and headquartered in Fairfield, Connecticut, United States...
and Philips
Philips
Koninklijke Philips Electronics N.V. , more commonly known as Philips, is a multinational Dutch electronics company....
.
Operations
BTG earns revenues from product sales and royalties from marketed products. These include CroFab, an antidote used to treat mild or moderate envenomation from Crotalid snakes, which includes rattlesnakes, found in the US and DigiFab, an antidote to treat patients with life-threatening digoxin (digitalis) toxicity or overdose.The Company's active development pipeline includes the following products:
- Voraxaze - for methotrexateMethotrexateMethotrexate , abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It acts by inhibiting the metabolism of folic acid. Methotrexate...
elimination - Varisolve - for varicose veins
- OncoGel - for oesophagealcancerCancerCancer , known medically as a malignant neoplasm, is a large group of different diseases, all involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumors, and invade nearby parts of the body. The cancer may also spread to more distant parts of the...
- Angiotensin Therapeutic Vaccine - for hypertensionHypertensionHypertension or high blood pressure is a cardiac chronic medical condition in which the systemic arterial blood pressure is elevated. What that means is that the heart is having to work harder than it should to pump the blood around the body. Blood pressure involves two measurements, systolic and...
- Pleneva (BGC20-0134) - for multiple sclerosis
- BGC20-1531 for migraine
In addition BTG has several programmes it intends to partner as they reach key development milestones.
See also
- Medical research
- National Enterprise BoardNational Enterprise Board-History:The National Enterprise Board was set up in the United Kingdom in 1975 to implement the Wilson Labour government's objective of extending public ownership of industry...
- National Research Development CorporationNational Research Development CorporationThe National Research Development Corporation was a non-departmental government body established by the British Government to transfer technology from the public sector to the private sector.-History:...